Business WireMerck Expands Colorectal Cancer Portfolio Through License Agreement with Inspirna First-in-class ompenaclide (RGX-202) is currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer. .17 hours ago
← PREVIOUS ARTICLE
Samantha’s colorful and courageous journey | Phoenix Children’s Hospital
NEXT ARTICLE →
Cureus Isolated perforation of multiple jejunal diverticula: a very rare cause of acute abdominal Solitary jejunal diverticulum (JD) perforation is extremely rare. It usually presents and is often discovered as a diagnostic dilemma. …1 day ago